Resource and Technical AdvanceIn-Press PreviewCOVID-19Virology Free access | 10.1172/jci.insight.139042
1Department of Pathology, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America
2Division of Diagnostics, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America
3Division of Molecular and Translational Science, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America
4Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, NIH, Frederick, United States of America
Find articles by Liu, J. in: PubMed | Google Scholar
1Department of Pathology, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America
2Division of Diagnostics, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America
3Division of Molecular and Translational Science, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America
4Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, NIH, Frederick, United States of America
Find articles by Babka, A. in: PubMed | Google Scholar
1Department of Pathology, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America
2Division of Diagnostics, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America
3Division of Molecular and Translational Science, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America
4Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, NIH, Frederick, United States of America
Find articles by Kearney, B. in: PubMed | Google Scholar
1Department of Pathology, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America
2Division of Diagnostics, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America
3Division of Molecular and Translational Science, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America
4Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, NIH, Frederick, United States of America
Find articles by
Radoshitzky, S.
in:
PubMed
|
Google Scholar
|
1Department of Pathology, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America
2Division of Diagnostics, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America
3Division of Molecular and Translational Science, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America
4Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, NIH, Frederick, United States of America
Find articles by
Kuhn, J.
in:
PubMed
|
Google Scholar
|
1Department of Pathology, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America
2Division of Diagnostics, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America
3Division of Molecular and Translational Science, United States Army Medical Research Institute of Infectious Diseases, Frederick, United States of America
4Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, NIH, Frederick, United States of America
Find articles by Zeng, X. in: PubMed | Google Scholar
Published May 7, 2020 - More info
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of human coronavirus disease 2019 (COVID-19), emerged in Wuhan, China in December 2019. The virus rapidly spread globally, resulting in a public-health crisis including more than 3.1 million cases and 224,000 deaths as of May 1, 2020. Here, we describe the identification and evaluation of commercially available reagents and assays for the molecular detection of SARS-CoV-2 in infected formalin fixed paraffin embedded (FFPE) cell pellets. We identified a suitable rabbit polyclonal anti-SARS-CoV spike protein antibody and a mouse monoclonal anti-SARS-CoV nucleocapsid protein (NP) antibody for cross detection of the respective SARS-CoV-2 proteins by immunohistochemistry (IHC) and immunofluorescence assay (IFA). Next, we established RNAscope in situ hybridization (ISH) to detect SARS-CoV-2 RNA. Furthermore, we established a multiplex fluorescence ISH (mFISH) to detect positive-sense SARS-CoV-2 RNA and negative-sense SARS-CoV-2 RNA (a replicative intermediate indicating viral replication). Finally, we developed a dual staining assay using IHC and ISH to detect SARS-CoV-2 antigen and RNA in the same FFPE section. These reagents and assays will accelerate COVID-19 pathogenesis studies in humans and in COVID-19 animal models.